Next Article in Journal
Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties
Previous Article in Journal
Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 12
Issue 5
10.3390/antibiotics12050823
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biocide Susceptibility and Antimicrobial Resistance of Escherichia coli Isolated from Swine Feces, Pork Meat and Humans in Germany

by
David Attuy Vey da Silva
1,2,
Ralf Dieckmann
1,*,
Oliwia Makarewicz
3,
Anita Hartung
3,
Astrid Bethe
4,5,
Mirjam Grobbel
1,
Vitaly Belik
6,
Mathias W. Pletz
3,
Sascha Al Dahouk
1,7,† and
Szilvia Neuhaus
1,*
1
Department of Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany
2
Department of Veterinary Medicine, Freie Universität Berlin, 14163 Berlin, Germany
3
Institute for Infectious Diseases and Infection Control, Jena University Hospital, 07747 Jena, Germany
4
Institute of Microbiology and Epizootics, Centre for Infection Medicine, Department of Veterinary Medicine, Freie Universität Berlin, 14163 Berlin, Germany
5
Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, 14163 Berlin, Germany
6
System Modeling Group, Institute of Veterinary Epidemiology and Biostatistics, Department of Veterinary Medicine, Freie Universität Berlin, 14163 Berlin, Germany
7
Department of Internal Medicine, RWTH Aachen University Hospital, 52074 Aachen, Germany
*
Authors to whom correspondence should be addressed.
†
Current address: Department of Environmental Hygiene, German Environment Agency, 14195 Berlin, Germany.
Antibiotics 2023, 12(5), 823; https://doi.org/10.3390/antibiotics12050823
Submission received: 6 April 2023 / Revised: 25 April 2023 / Accepted: 26 April 2023 / Published: 27 April 2023
(This article belongs to the Section Antibiotics in Animal Health)
Browse Figure
Versions Notes

Abstract

:
Phenotypic susceptibility testing of Escherichia (E.) coli is an essential tool to gain a better understanding of the potential impact of biocide selection pressure on antimicrobial resistance. We, therefore, determined the biocide and antimicrobial susceptibility of 216 extended-spectrum β-lactamase-producing (ESBL) and 177 non-ESBL E. coli isolated from swine feces, pork meat, voluntary donors and inpatients and evaluated associations between their susceptibilities. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of benzalkonium chloride, chlorhexidine digluconate (CHG), chlorocresol (PCMC), glutaraldehyde (GDA), isopropanol (IPA), octenidine dihydrochloride and sodium hypochlorite (NaOCl) showed unimodal distributions, indicating the absence of bacterial adaptation to biocides due to the acquisition of resistance mechanisms. Although MIC95 and MBC95 did not vary more than one doubling dilution step between isolates of porcine and human origin, significant differences in MIC and/or MBC distributions were identified for GDA, CHG, IPA, PCMC and NaOCl. Comparing non-ESBL and ESBL E. coli, significantly different MIC and/or MBC distributions were found for PCMC, CHG and GDA. Antimicrobial susceptibility testing revealed the highest frequency of resistant E. coli in the subpopulation isolated from inpatients. We observed significant but weakly positive correlations between biocide MICs and/or MBCs and antimicrobial MICs. In summary, our data indicate a rather moderate effect of biocide use on the susceptibility of E. coli to biocides and antimicrobials.

1. Introduction

Biocides have been applied for decades as disinfectants, antiseptics and preservatives in healthcare settings and along the food production chain, and they play a major role in the prevention of zoonotic diseases [1,2]. However, concerns have been raised that the widespread use of biocides may contribute to the development and spread of biocide and antimicrobial resistance [3,4]. This trend may be accelerated by the COVID-19 pandemic [5] and future pandemics that require extensive biocide usage for prevention and control.
Epidemiological studies identified temporal associations between the application of biocidal substances and a decreasing susceptibility of bacteria to these substances of interest [6,7]. Hardy and colleagues demonstrated an association between the introduction and increased usage of the antiseptics chlorhexidine digluconate (CHG) and octenidine dihydrochloride (OCT) in a hospital and a reduced susceptibility of Staphylococcus (S.) aureus to both substances [6]. Similarly, Pidot and colleagues [7] showed that the wide use of handwash alcohols in two hospitals was associated with a reduced susceptibility of Enterococcus faecium to isopropanol (IPA). In a recent outbreak investigation, we identified carbapenem-resistant Klebsiella (K.) pneumoniae isolates with a decreased susceptibility to CHG in an intensive care unit where patients were routinely washed with CHG to decrease the rate of catheter-related infections [8]. As a matter of concern, reduced CHG susceptibility was associated with resistance to colistin (COL), which was likely caused by an increased efflux of both substances via the same route. Laboratory adaptation studies provide evidence that bacterial exposure to biocides can lead to resistance and cross-resistance to antimicrobials (reviewed in [3]). Dopcea and colleagues [9] showed that in vitro exposure of clinical S. aureus to CHG resulted in a reduced susceptibility to this antiseptic as well as to gentamicin (GEN), penicillin or tetracycline (TET) in several of the investigated strains. Similarly, contact of Escherichia (E.) coli, Listeria monocytogenes, Campylobacter coli and Salmonella enterica with increasing subinhibitory concentrations of the quaternary ammonium compound (QAC) didecyldimethylammonium chloride led to reduced biocide susceptibility and to bacterial antimicrobial resistance (AMR) [10]. AMR is a growing threat to animal and human health and to food safety [11]. AMR is caused by the bacterial mechanisms rendering the drugs used to treat infections less effective [12]. However, numerous studies reported contrasting results on the relevance of biocidal use on the development and spread of AMR. For instance, the absence of bacterial adaptation to biocides in field isolates as well as missing or weak associations between biocide and antimicrobial susceptibility contribute to the controversial discussion of this topic [13,14,15,16,17].
E. coli is a gram-negative indicator organism to monitor AMR trends [18,19,20]. The microorganism can persist for varying periods of time in the environment [21]. Persistent colonization of food-processing plants can result in recurrent food contamination [22]. Furthermore, E. coli is an important nosocomial pathogen [23,24,25]. Previous studies reported the localization of biocide resistance genes such as the efflux pump encoding genes qacE∆1, qacF, qacH and sugE(p) on extended-spectrum β-lactamase (ESBL) plasmids in E. coli [26,27,28]. The colocalization of biocide and antimicrobial resistance genes on plasmids may provide a selective advantage to ESBL E. coli in higher biocide concentrations.
In our study, we investigated the susceptibility of 393 E. coli isolates from four different sources, namely primary production (swine feces), food (pork meat), voluntary donors and inpatients, to seven widely used biocides. The study population included 216 ESBL and 177 non-ESBL E. coli. According to their origin or ESBL carriage, we comparatively analyzed the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) data of E. coli to identify characteristics potentially specific to the different subpopulations. Furthermore, we determined their bacterial susceptibility to 15 antimicrobials and assessed associations between reduced biocide susceptibility and antimicrobial resistance.

2. Results

2.1. Biocide Susceptibility

MICs and MBCs of glutaraldehyde (GDA), CHG, benzalkonium chloride (BAC), OCT, IPA, sodium hypochlorite (NaOCl) and chlorocresol (PCMC) were determined for 393 E. coli isolated from swine feces, pork meat, voluntary donors and inpatients (Table 1 and Table 2). Overall, MIC and MBC data showed non-normal, unimodal distributions for all biocides ranging from three to six (MIC data, Table 1) and from four to seven (MBC data, Table 2) dilution steps. The majority of MICs clustered within one or two consecutive concentrations for all biocides tested. The most predominant MICs of GDA, CHG, BAC, OCT, IPA, NaOCl and PCMC were 256–512 mg/L (94%), 1–2 mg/L (91%), 16–32 mg/L (94%), 2 mg/L (96%), 32,768–65,536 mg/L (95%), 256–512 mg/L (97%) and 256–512 mg/L (99%), respectively. The majority of MBCs clustered at equal or slightly higher concentrations than the corresponding MICs, i.e., 512–1024 mg/L for GDA (92%), 1–4 mg/L for CHG (94%), 16–64 mg/L for BAC (98%), 2–4 mg/L for OCT (94%), 65,536–131,072 mg/L for IPA (88%), 512–1024 mg/L for NaOCl (98%) and 512–1024 mg/L for PCMC (99%). Table S1 provides information on the MIC and MBC results for all isolates and substances tested.
The initial comparative analysis of MIC95 and MBC95 values revealed minor variation. MIC95 and MBC95 values were the same (MIC95 of OCT and PCMC, MBC95 of BAC and NaOCl) or differed by only one dilution step between the four E. coli subpopulations of different origin (Table 1 and Table 2). Despite the low variability of MIC95 and MBC95, statistical analysis using the Kruskal–Wallis test revealed significant differences in the MIC and/or MBC distributions for GDA, CHG, IPA, PCMC and NaOCl depending on the source of isolation (Table 1 and Table 2). Subsequently, we identified which of the four subgroups yielded significantly different MIC and/or MBC distributions by applying the post hoc Dunn–Bonferroni test (Table S2a,b). The inpatient isolates exhibited significantly higher GDA MICs and MBCs in comparison to isolates from pork meat and swine feces as well as significantly higher IPA MICs compared to isolates from voluntary donors. Isolates from pork meat showed significantly lower CHG MICs and MBCs compared to the other three subpopulations and significantly higher IPA MICs compared to isolates from swine feces and inpatients. Additionally, MIC95 and/or MBC95 values differed between the 177 non-ESBL and the 216 ESBL E. coli for GDA, BAC, CHG, OCT and PCMC (Table S3a,b). ESBL E. coli showed twofold higher MIC95 values for GDA and BAC as well as for the CHG MBC95 compared to non-ESBL E. coli. In contrast, the MBC95 of OCT and PCMC was twofold lower in ESBL E. coli. Statistically significant differences between these two subgroups were only found for the MIC of PCMC (p = 0.003) as well as the MBC of GDA (p = 0.040) and CHG (p = 0.021).

2.2. Antimicrobial Susceptibility

The antimicrobial resistance profiles of 216 ESBL and 177 non-ESBL E. coli are summarized in Table 3. AMR results are provided in Table S4. Resistance to ampicillin (AMP), sulfamethoxazole (SME), trimethoprim (TRI) and TET was most frequently observed. Resistance to ciprofloxacin (CIP), nalidixic acid (NAL), azithromycin (AZI), chloramphenicol (CHL) and GEN was less frequent. Low resistance rates were found for COL, meropenem (MER) and tigecycline (TIG).
The proportion of isolates resistant to SME, TRI, CIP, NAL, AZI and GEN was higher in the subpopulation isolated from humans than those from swine feces and pork meat. Resistances against TET and CHL were evenly distributed among subgroups (Figure 1). Isolates from inpatients generally displayed the highest frequency of antimicrobial resistance, but they were all susceptible to COL and TIG. We detected only a low resistance rate to MER, with four resistant isolates from inpatients and one from a voluntary donor. COL- and TIG-resistant isolates were rare and were mainly found in swine feces, except for two non-ESBL isolates from voluntary donors and one non-ESBL isolate from pork meat. A total of 251 out of 393 (64%) isolates were resistant to three or more classes of antimicrobials (200 ESBL and 51 non-ESBL E. coli), and therefore, they were defined as multidrug-resistant (MDR).

2.3. Association between Antimicrobial and Biocide Susceptibility

Significant positive correlations between high MIC and MBC values in biocides and increased MICs in antimicrobials were found in the total E. coli population (Table 4) and within each subgroup (Table S5a,b). Correlation coefficients (rs) ranged from rs = 0.099 to rs = 0.280 in the total population and from rs = 0.201 to rs = 0.376 within the four origin-related subgroups. In addition, non-ESBL and ESBL E. coli isolates were tested separately, and the correlation coefficients ranged from rs = 0.138 to rs = 0.307.
In the total E. coli population, significant positive correlation coefficients were highest between CHG MBC and NAL MIC (rs = 0.280), CHG MBC and CIP MIC (rs = 0.276), CHG MIC and GEN MIC (rs = 0.228), as well as CHG MIC and MBC and TET MIC (MIC: rs = 0.229; MBC: rs = 0.246). Significant positive correlation coefficients within subgroups were highest for BAC MIC and MBC and ceftazidime (CTZ) MIC in isolates from voluntary donors (MIC: rs = 0.312, MBC: rs = 0.376) and for CHG MIC and MBC and TET MIC in isolates from pork meat (MIC: rs = 0.370, MBC: rs = 0.344). The highest positive and significant correlation coefficient in the non-ESBL and ESBL E. coli subpopulations was determined for BAC MBC and CTZ MIC (rs = 0.307) in non-ESBL isolates. In ESBL isolates, the highest correlation coefficient was observed for CHG MBC and CIP MIC (rs = 0.259).

3. Discussion

In our study, we investigated biocide and antimicrobial susceptibility in a large E. coli population (n = 393) including 55% (n = 216) ESBL E. coli originating from human (voluntary donors and inpatients) and swine (feces and pork meat) samples to better understand the potential impact of biocide usage on the spread of biocide and antimicrobial-resistant bacteria. We determined distributions of MICs and MBCs for biocidal substances frequently used in animal husbandry, along the food chain and/or in human healthcare settings.
MIC and MBC data showed unimodal distributions, indicating that the investigated E. coli did not acquire biocide resistance. OCT and PCMC MIC95 values as well as BAC and NaOCl MBC95 values were the same for all subgroups. For all other substances tested, we observed slightly different MIC95 and/or MBC95 values in isolates from inpatients, voluntary donors, swine feces and pork meat. Overall, there was only one doubling dilution step difference in MIC95 and/or MBC95 values between subgroups. For example, twofold higher MIC95 values of CHG were determined for isolates from humans and swine feces (4 mg/L) compared to pork meat isolates (2 mg/L). A similar variability was described by Deus and colleagues, who compared MIC90 values of isolates from poultry (1 mg/L) and humans (2 mg/L) [27]. A higher MIC90 of CHG at 16 mg/L was reported previously for E. coli isolates from hospital patients [14]. Indeed, concerns have been raised about associations between increasing CHG usage in healthcare and an increased MIC of CHG, cross-resistance with antimicrobials and their link to multidrug resistance [29]. In contrast, the comparison of MIC95 and MBC95 values in our study population indicates rather low variability of biocide susceptibility in different settings independent of the underlying selection pressure. Nevertheless, statistical analysis revealed significant differences in MIC and/or MBC distributions between subpopulations. This might reflect diverse usage patterns of biocidal substances in these four settings. One limitation of our study is that we did not obtain information on the biocides applied or their frequency of use in the sampled areas. Therefore, it is impossible to draw conclusions regarding whether usage patterns may influence biocide susceptibility in E. coli. Nonetheless, according to our data, even high selection pressure due to frequent application of disinfectants, antiseptics and antimicrobials (e.g., E. coli of hospitalized patients compared to isolates from voluntary donors) seems to have a rather moderate impact on the development of reduced susceptibility to tested substances in E. coli. However, single isolates showed considerably high MIC and/or MBC values.
The MIC ranges observed for BAC, CHG, PCMC, NaOCl and GDA in our study were consistent with those of previous studies that investigated E. coli isolates from livestock [15,30,31,32], meat [26] and human samples [14,27]. Hitherto, interpretative criteria to distinguish biocide resistant from susceptible E. coli isolates are missing, impeding the assessment of biocide susceptibility data [33]. Tentative epidemiological cut-offs (ECOFFs) based on MIC90, MIC95 or MIC99.9 values of clinically relevant microorganisms including E. coli have been proposed [14,15,27]. Morrissey and colleagues defined ECOFFs for CHG (MIC99.9 = 64 mg/L, MBC99.9 > 64 mg/L), BAC (MIC99.9 = 64 mg/L, MBC99.9 = 128 mg/L) and NaOCl (MIC99.9 = 8.2 g/L, MBC99.9 = 16.4 g/L) considering 368 E. coli isolates collected between 1998 and 2011 [14]. The results obtained in our study for CHG and NaOCl were below these reported tentative ECOFFs, whereas 22 isolates yielded BAC MIC or MBC values above the published thresholds. The observation of similar susceptibilities to CHG, BAC and NaOCl in E. coli isolated from various environments geographically and temporally widely dispersed indicates a lack of adaptation to tested substances in the recent past. However, comparing MIC and MBC values across studies remains a challenge because experimental standards for biocide susceptibility testing (BST) are still missing. Therefore, harmonized experiments and standardized methods are essential. Despite the recent development of quality control (QC) ranges for BST [34], standardized ECOFFs or specific breakpoints to define isolates with a reduced susceptibility to biocides still lag behind.
To determine putative associations between an ESBL phenotype and reduced biocide susceptibility, we comparatively analyzed the MIC and MBC distributions of ESBL and non-ESBL E. coli. Susceptibility to BAC, IPA, NaOCl, PCMC and OCT was comparable for ESBL and non-ESBL E. coli, indicating that ESBL-carriage does not benefit survival during contact with these substances. Even though the MIC95 and MBC95 values of GDA, CHG and PCMC only differed in one doubling dilution step between both groups, statistically significant differences were observed in GDA and CHG MBC distributions as well as in PCMC MIC distributions. Although GDA and CHG MBCs of ESBL E. coli shifted towards higher values compared to the non-ESBL subpopulation, increased PCMC MICs were found in the non-ESBL subset. In our study, we did not observe higher MIC values for the quaternary ammonium compound BAC in ESBL E. coli, as previously described [27]. The association observed between the ESBL phenotype and decreased susceptibility to GDA and CHG might be explained by the genetic relatedness of resistance mechanisms.
Interpretation of antimicrobial susceptibility testing data using ECOFFs is a powerful tool for the surveillance of antimicrobial resistance [35]. Further, ECOFFs allow for comparing the development of antimicrobial resistance in bacteria irrespective of their origin [36]. Accordingly, we comparatively analyzed AST data of our study population based on ECOFFs [35]. To enable comparison of AMR in E. coli of human origin (inpatients and voluntary donors) with reports from national and international surveillance systems, we considered clinical breakpoints [37] instead of ECOFFs.
Overall, 64% of the tested isolates (57% from healthcare settings and 43% from swine) were resistant to three or more classes of antimicrobials and were thereby classified as MDR. MDR E. coli have been widely reported in livestock [15,38,39], food [40] and nosocomial infections [41,42,43,44,45]. As expected, the highest resistance rates to most of the substances, including AMP, SME, TRI, CIP, NAL and AZI, were found in isolates from hospital patients. Non-ESBL isolates from inpatients also showed higher resistance rates to the listed antimicrobials compared to non-ESBL isolates from other subpopulations. In accordance with this, resistance of E. coli to AMP, CIP and TRI has been frequently documented in the German antimicrobial resistance surveillance database (ARS) [46]. In our study population, we identified isolates bearing MER resistance, whereas this resistance has not been documented in ARS in the last five years. However, the MER resistance rates found in our study are consistent with previous results [47]. A low number of isolates were resistant to last-resort antimicrobials such as COL and TIG [48]. The World Health Organization recommends the restricted use of both substances exclusively for the treatment of life-threatening infections due to MDR bacteria [48,49]. We identified COL- and TIG-resistant E. coli isolates predominantly from swine feces. Interestingly, neither resistance to COL nor to TIG were reported within the German National Zoonoses Monitoring Program for E. coli of porcine origin in 2019 [50]. However, COL-resistant E. coli have been isolated from German swine farms in the recent past [51]. TIG resistance in E. coli from swine has been previously reported from the United Kingdom, South Africa and Thailand [52,53,54]. When comparing E. coli AMR data from swine feces and pork meat sampled in our study with reporting data from the German National Zoonoses Monitoring Program as well as with human data with resistance rates documented in ARS, the high number of ESBL E. coli included in our study group has to be considered (ranging from 44 to 74% in the four subpopulations). Accordingly, resistance rates were generally higher in the isolates included in our study.
Cross-resistance and co-resistance are discussed as potential drivers for biocide-induced emergence and the spread of antimicrobial resistance [55,56,57,58]. Cross-resistant bacteria have developed one specific mechanism enabling survival at higher concentrations of various antibacterial substances, e.g., biocides and antimicrobials [55]. Examples are the cross-resistance of K. pneumoniae to COL and CHG [8,59] and the cross-resistance of Acinetobacter baumannii to multiple antimicrobials and triclosan [60]. Co-resistance describes the colocalization of two or more resistance genes encoding for independent resistance mechanisms, which are transferred in a single event and expressed jointly in a new bacterial cell [55,61]. Roedel and colleagues [15] described the colocalization of QAC resistance determinants and antimicrobial resistance genes on mobile genetic elements. Associations between increased biocide and antimicrobial MICs are indicators for co-selection due to cross- or co-resistance. Correlation analysis has often been used to investigate such associations [15,62,63]. In our study, several significant positive correlations between tested biocidal substances and antimicrobials were observed, which were all classified as weak [62]. Hence, our phenotypic data do not provide strong evidence that biocide and antimicrobial resistance are linked. Biocides act against bacterial cells at multiple target sites [55]. Accordingly, different mechanisms such as efflux, degradation and impermeability or even their synergistic action may enable bacteria to survive higher concentrations of a specific biocide. The diversity of bacterial protection mechanisms might be one possible explanation for the weak correlations we observed. Further, it has been shown that prolonged bacterial exposure to low biocide concentrations may result in AMR development, which is not accompanied by a stable decrease in biocide susceptibility [64,65]. Because this pathway to antimicrobial resistance induced by biocides is unrelated to changes in biocide MICs, it cannot be detected with the approach of our study.
In conclusion, our data lack the clear evidence that E. coli field isolates have adapted to tested biocidal substances in the recent past. Even though we found statistically significant differences for MIC and MBC distributions between subgroups, the low variability of phenotypic susceptibility data suggests a rather low impact of niche-specific selection pressure on the adaptation of E. coli to biocides. Whether the identified correlations between biocide and antimicrobial susceptibility are related to co- or cross-resistance needs to be elucidated in mechanistic analyses.

4. Materials and Methods

4.1. E. coli Isolates

In total, 393 E. coli strains were investigated in our study, including 216 ESBL and 177 non-ESBL phenotypes. E. coli isolated from humans originated from the strain collection of the Institute of Infectious Diseases and Infection Control of Jena University Hospital. These isolates were obtained from previous research projects (see section Institutional Review Board Statement). Specifically, rectal swabs were collected from two groups: 96 voluntary donors in 2018 and 98 colonized hospital patients (inpatients) between 2014 and 2017. Isolates of porcine origin comprised 100 E. coli from the strain collection of the Institute of Microbiology and Epizootics isolated from swine fecal samples collected at 15 German swine farms in 2016 and 99 pork meat isolates from the National Reference Laboratory for Antimicrobial Resistance located at the German Federal Institute for Risk Assessment (BfR). E. coli from pork meat were obtained from the German National Zoonoses Monitoring Program in 2015 and 2017, following the requirements of commission implementing decision (CID) 2013/652/EU. The ESBL phenotypes of all isolates were determined in their respective diagnostic laboratories using either VITEK®-2 (bioMérieux Inc., Durham, NC, USA) testing (VITEK®-2 software release 8.01) with the AST-GN69 card or using the ESBL confirmatory test according to the Clinical and Laboratory Standards Institute (CLSI) recommendations. Isolates were stored in glycerol stocks and were grown on Mueller–Hinton (MH) agar (Thermo Fisher Diagnostics GmbH Microbiology, Wesel, Germany) overnight at 37 °C before use.

4.2. Biocides

The susceptibility of E. coli to seven biocides frequently added to antiseptics and disinfectants applied in healthcare and food production was tested, namely GDA (Carl Roth, Karlsruhe, Germany), CHG (Sigma Aldrich, Steinheim, Germany), BAC (Sigma Aldrich), OCT (Thermo Fisher Scientific, Schwerte, Germany), IPA (Carl Roth), NaOCl (AppliChem, Darmstadt, Germany) and PCMC (Sigma Aldrich). The concentrated chemical solutions were freshly diluted prior to the experiments with standardized hard water as defined in EN 1276. Serial twofold dilutions were prepared in 96-well plates within the following concentration ranges: 8192 to 64 mg/L of GDA, 64 to 0.5 mg/L of CHG, 256 to 2 mg/L of BAC, 32 to 0.25 mg/L of OCT, 262,144 to 2048 mg/L of IPA, 4096 to 64 mg/L of NaOCl and 8192 to 64 mg/L of PCMC.

4.3. Biocide Susceptibility Testing

The MICs and MBCs of all isolates to each biocide were determined via broth microdilution as previously reported [15]. Briefly, overnight cultures grown on Mueller–Hinton agar (MHA, Mast Diagnostica GmbH, Reinfeld, Germany) were adjusted to 106 colony-forming units (CFU) per milliliter of double-concentrated Mueller–Hinton broth (MHB, Mast Diagnostica GmbH). In a 96-well microtiter plate (Greiner Bio One, Frickenhausen, Germany), 50 μL of this bacterial solution was mixed with 50 μL of the twofold-concentrated biocide. The plates were incubated at 37 °C for 20 ± 2 h. Optical density (OD595 nm) was measured after 5 s of shaking using an iMark Microplate Absorbance Reader (Bio-Rad, Feldkirchen, Germany). Bacterial growth was compared to a negative control (microtiter plate containing biocide solution and MHB), and ΔOD595 nm = 0.08 was set as the cut-off. The MIC was defined as the lowest concentration of a biocide at which no growth was observed.
For MBC determination, 20 μL each from those wells without detectable bacterial growth and those with the lowest concentration of biocides at which bacterial growth was only just observed were added to 180 μL of Dey–Engley neutralizing broth solution (Sigma Aldrich) to quench biocidal effects. After a short incubation period (5 min), 25 μL were plated on MHA in duplicates and incubated at 37 °C for 24 h. Dey–Engley neutralizing broth solution was prepared according to the manufacturer’s recommendations. Neutralizer efficacy and toxicity were assessed prior to MIC and MBC testing according to the process of Roedel and colleagues [15]. The MBC was defined as the lowest concentration of the biocide at which no bacterial colonies on MHA were observed. The reference strain E. coli ATCC 25922 was used as an internal quality control in both MIC and MBC tests and showed comparable results throughout the experiments. To evaluate the reproducibility of the MIC and MBC tests, both methods were performed in two biological replicates on separate days for a subset of 43 E. coli (>10% of the study population) and all biocides. MIC or MBC variations of one dilution step between the two experiments were accepted. The lower concentration was defined as MIC or MBC. In case of higher variations, we repeated the test for a third time, and the median was considered to be the final MIC or MBC (data not shown). The lowest biocide concentration inhibiting growth of 95% of the bacterial population was designated as MIC95, and the lowest lethal concentration killing 95% of the bacterial population was designated as MBC95.

4.4. Antimicrobial Susceptibility Testing

The susceptibility of E. coli to antimicrobials was determined via broth microdilution following CLSI guidelines [66] using the Sensititre system with EUVSEC and EUVSEC3 plates (Thermo Fisher Scientific) in concordance with the decisions 2013/652/EU and 2020/1729/EU of the European Union. We analyzed antimicrobial resistance to a variety of substances, namely: AMP, cefotaxime, CTZ, MER, NAL, CIP, GEN, TET, TIG, COL, SME, TRI, CHL and AZI. We defined resistance using ECOFFs according to the European Committee for Antimicrobial Susceptibility Testing (EUCAST) [35] and the decision CID 2020/1729/EU of the European Union.

4.5. Statistical Analysis

Biocide MIC and MBC data were tested for normal distribution using the Kolmogorov–Smirnov test. Comparison of MIC and MBC values between isolates of human and porcine origin (four subgroups) was performed using the Kruskal–Wallis test and the post hoc Dunn–Bonferroni test. The Mann–Whitney test was applied to evaluate differences between non-ESBL and ESBL E. coli. Differences were considered significant at p-values < 0.05. Correlations between biocide susceptibility and antimicrobial resistance were evaluated by calculating Spearman’s rank coefficients (rs). Positive correlations were defined as weak (0.1 ≤ rs < 0.4), moderate (0.4 ≤ rs < 0.7) or strong (0.7 ≤ rs < 1) [62], and significance was considered at p-values < 0.05. All statistical tests were carried out with SPSS (IBM SPSS Statistics, Version 21, IBM Corp., Armonk, NY, USA).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics12050823/s1, Table S1: Biocide susceptibility of 393 E. coli; Table S2a: Pairwise comparisons of MIC distributions of E. coli of human and porcine origin; Table S2b: Pairwise comparisons of MBC distributions of E. coli of human and porcine origin; Table S3a: Minimum inhibitory concentrations of biocides in non-ESBL and ESBL E. coli isolates; Table S3b: Minimum bactericidal concentrations of biocides in non-ESBL and ESBL E. coli isolates; Table S4: Antimicrobial susceptibility of 393 E. coli; Table S5a: Significant positive correlation coefficients (rs) between biocides and antimicrobials in E. coli of human and porcine origin; Table S5b: Significant positive correlation coefficients (rs) between biocides and antimicrobials in non-ESBL and ESBL E. coli.

Author Contributions

Conceptualization, S.N., V.B., S.A.D. and R.D.; methodology, D.A.V.d.S., S.N. and M.G.; software, D.A.V.d.S., S.N. and M.G.; validation, D.A.V.d.S., S.N., R.D. and S.A.D.; formal analysis, D.A.V.d.S., S.N. and R.D.; investigation, D.A.V.d.S., S.N., O.M., A.H., A.B. and M.G.; resources, O.M., A.H., A.B., M.W.P. and M.G.; data curation, D.A.V.d.S., S.N. and R.D.; writing—original draft preparation, D.A.V.d.S., S.N. and R.D.; writing—review and editing, all authors; visualization, D.A.V.d.S., S.N. and R.D.; supervision, S.N., S.A.D., V.B. and R.D.; project administration, D.A.V.d.S., S.N., V.B., S.A.D. and R.D.; funding acquisition, S.N., S.A.D. and R.D. All authors have read and agreed to the published version of the manuscript.

Funding

The Federal Ministry of Education and Research (BMBF) funded this study under project number FKZ 01KI1907 in the framework of the German Research Platform for Zoonoses.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Jena University Hospital (Nr. 3852-07/13, approved on 14 August 2013, and Nr. 5375-12/17 approved on 22 January 2018).

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are presented within the text and in the Supplementary Materials.

Acknowledgments

We thank Anna-Louisa Hauffe, Samer Sebastian Jassim, Britta Lesniewsky, Kathrin Oelgeschlaeger and Yvonne Klaar for excellent technical assistance.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; in the decision to publish the results.

References

  1. McDonnell, G.; Russell, A.D. Antiseptics and disinfectants: Activity, action, and resistance. Clin. Microbiol. Rev. 1999, 12, 147–179. [Google Scholar] [CrossRef] [PubMed]
  2. Butucel, E.; Balta, I.; Ahmadi, M.; Dumitrescu, G.; Morariu, F.; Pet, I.; Stef, L.; Corcionivoschi, N. Biocides as biomedicines against foodborne pathogenic bacteria. Biomedicines 2022, 10, 379. [Google Scholar] [CrossRef] [PubMed]
  3. Kampf, G. Biocidal agents used for disinfection can enhance antibiotic resistance in gram-negative species. Antibiotics 2018, 7, 110. [Google Scholar] [CrossRef] [PubMed]
  4. Meade, E.; Slattery, M.A.; Garvey, M. Biocidal resistance in clinically relevant microbial species: A major public health risk. Pathogens 2021, 10, 598. [Google Scholar] [CrossRef] [PubMed]
  5. Mahoney, A.R.; Safaee, M.M.; Wuest, W.M.; Furst, A.L. The silent pandemic: Emergent antibiotic resistances following the global response to SARS-CoV-2. iScience 2021, 24, 102304. [Google Scholar] [CrossRef]
  6. Hardy, K.; Sunnucks, K.; Gil, H.; Shabir, S.; Trampari, E.; Hawkey, P.; Webber, M. Increased usage of antiseptics is associated with reduced susceptibility in clinical isolates of Staphylococcus aureus. MBio 2018, 9, e00894-18. [Google Scholar] [CrossRef]
  7. Pidot, S.J.; Gao, W.; Buultjens, A.H.; Monk, I.R.; Guerillot, R.; Carter, G.P.; Lee, J.Y.H.; Lam, M.M.C.; Grayson, M.L.; Ballard, S.A.; et al. Increasing tolerance of hospital Enterococcus faecium to handwash alcohols. Sci. Transl. Med. 2018, 10, eaar6115. [Google Scholar] [CrossRef]
  8. Stein, C.; Vincze, S.; Kipp, F.; Makarewicz, O.; Al Dahouk, S.; Pletz, M.W. Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility. Lancet Infect. Dis. 2019, 19, 932–933. [Google Scholar] [CrossRef]
  9. Dopcea, G.N.; Dopcea, I.; Nanu, A.E.; Diguţă, C.F.; Matei, F. Resistance and cross-resistance in Staphylococcus spp. strains following prolonged exposure to different antiseptics. J. Glob. Antimicrob. Resist. 2020, 21, 399–404. [Google Scholar] [CrossRef]
  10. Soumet, C.; Méheust, D.; Pissavin, C.; Le Grandois, P.; Frémaux, B.; Feurer, C.; Le Roux, A.; Denis, M.; Maris, P. Reduced susceptibilities to biocides and resistance to antibiotics in food-associated bacteria following exposure to quaternary ammonium compounds. J. Appl. Microbiol. 2016, 121, 1275–1281. [Google Scholar] [CrossRef]
  11. WOAH. World Organization for Animal Health. Antimicrobial Resistance. 2023. Available online: https://www.woah.org/en/what-we-do/global-initiatives/antimicrobial-resistance/ (accessed on 2 February 2023).
  12. WHO. World Health Organization. Antimicrobial Resistance. 2021. Available online: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed on 1 February 2023).
  13. Russell, A.D. Biocide use and antibiotic resistance: The relevance of laboratory findings to clinical and environmental situations. Lancet Infect. Dis. 2003, 3, 794–803. [Google Scholar] [CrossRef]
  14. Morrissey, I.; Oggioni, M.R.; Knight, D.; Curiao, T.; Coque, T.; Kalkanci, A.; Martinez, J.L. Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms. PLoS ONE 2014, 9, e86669. [Google Scholar] [CrossRef]
  15. Roedel, A.; Vincze, S.; Projahn, M.; Roesler, U.; Robé, C.; Hammerl, J.A.; Noll, M.; Al Dahouk, S.; Dieckmann, R. Genetic but no phenotypic associations between biocide tolerance and antibiotic resistance in Escherichia coli from German broiler fattening farms. Microorganisms 2021, 9, 651. [Google Scholar] [CrossRef]
  16. Feßler, A.T.; Scholtzek, A.D.; Schug, A.R.; Kohn, B.; Weingart, C.; Hanke, D.; Schink, A.-K.; Bethe, A.; Lübke-Becker, A.; Schwarz, S. Antimicrobial and biocide resistance among canine and feline Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii isolates from diagnostic submissions. Antibiotics 2022, 11, 152. [Google Scholar] [CrossRef]
  17. Feßler, A.T.; Scholtzek, A.D.; Schug, A.R.; Kohn, B.; Weingart, C.; Schink, A.-K.; Bethe, A.; Lübke-Becker, A.; Schwarz, S. Antimicrobial and biocide resistance among feline and canine Staphylococcus aureus and Staphylococcus pseudintermedius isolates from diagnostic submissions. Antibiotics 2022, 11, 127. [Google Scholar] [CrossRef]
  18. Kaesbohrer, A.; Schroeter, A.; Tenhagen, B.-A.; Alt, K.; Guerra, B.; Appel, B. Emerging antimicrobial resistance in commensal Escherichia coli with public health relevance. Zoonoses Public Health 2012, 59, 158–165. [Google Scholar] [CrossRef]
  19. Tadesse, D.A.; Zhao, S.; Tong, E.; Ayers, S.; Singh, A.; Bartholomew, M.J.; McDermott, P.F. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerg. Infect. Dis. 2012, 18, 741–749. [Google Scholar] [CrossRef]
  20. Nyirabahizi, E.; Tyson, G.H.; Dessai, U.; Zhao, S.; Kabera, C.; Crarey, E.; Womack, N.; Crews, M.K.; Strain, E.; Tate, H. Evaluation of Escherichia coli as an indicator for antimicrobial resistance in Salmonella recovered from the same food or animal ceca samples. Food Control 2020, 115, 107280. [Google Scholar] [CrossRef]
  21. van Elsas, J.D.; Semenov, A.V.; Costa, R.; Trevors, J.T. Survival of Escherichia coli in the environment: Fundamental and public health aspects. ISME J 2011, 5, 173–183. [Google Scholar] [CrossRef]
  22. Oniciuc, E.-A.; Likotrafiti, E.; Alvarez-Molina, A.; Prieto, M.; López, M.; Alvarez-Ordóñez, A. Food processing as a risk factor for antimicrobial resistance spread along the food chain. Curr. Opin. Food Sci. 2019, 30, 21–26. [Google Scholar] [CrossRef]
  23. Behnke, M.; Aghdassi, S.J.; Hansen, S.; Diaz, L.A.P.; Gastmeier, P.; Piening, B. The prevalence of nosocomial infection and antibiotic use in German hospitals. Dtsch. Arztebl. Int. 2017, 114, 851–857. [Google Scholar] [CrossRef] [PubMed]
  24. Ludden, C.; Coll, F.; Gouliouris, T.; Restif, O.; Blane, B.; Blackwell, G.A.; Kumar, N.; Naydenova, P.; Crawley, C.; Brown, N.M.; et al. Defining nosocomial transmission of Escherichia coli and antimicrobial resistance genes: A genomic surveillance study. Lancet Microbe 2021, 2, e472–e480. [Google Scholar] [CrossRef] [PubMed]
  25. Stewart, S.; Robertson, C.; Pan, J.; Kennedy, S.; Dancer, S.; Haahr, L.; Manoukian, S.; Mason, H.; Kavanagh, K.; Cook, B.; et al. Epidemiology of healthcare-associated infection reported from a hospital-wide incidence study: Considerations for infection prevention and control planning. J. Hosp. Infect. 2021, 114, 10–22. [Google Scholar] [CrossRef] [PubMed]
  26. Zou, L.; Meng, J.; McDermott, P.F.; Wang, F.; Yang, Q.; Cao, G.; Hoffmann, M.; Zhao, S. Presence of disinfectant resistance genes in Escherichia coli isolated from retail meats in the USA. J. Antimicrob. Chemother. 2014, 69, 2644–2649. [Google Scholar] [CrossRef] [PubMed]
  27. Deus, D.; Krischek, C.; Pfeifer, Y.; Sharifi, A.R.; Fiegen, U.; Reich, F.; Klein, G.; Kehrenberg, C. Comparative analysis of the susceptibility to biocides and heavy metals of extended-spectrum β-lactamase-producing Escherichia coli isolates of human and avian origin, Germany. Diagn. Microbiol. Infect. Dis. 2017, 88, 88–92. [Google Scholar] [CrossRef]
  28. Haley, B.J.; Kim, S.W.; Salaheen, S.; Hovingh, E.; Van Kessel, J.A.S. Virulome and genome analyses identify associations between antimicrobial resistance genes and virulence factors in highly drug-resistant Escherichia coli isolated from veal calves. PLoS ONE 2022, 17, e0265445. [Google Scholar] [CrossRef]
  29. Van den Poel, B.; Saegeman, V.; Schuermans, A. Increasing usage of chlorhexidine in health care settings: Blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control. Eur. J. Clin. Microbiol. Infect. 2022, 41, 349–362. [Google Scholar] [CrossRef]
  30. Oosterik, L.H.; Peeters, L.; Mutuku, I.; Goddeeris, B.M.; Butaye, P. Susceptibility of avian pathogenic Escherichia coli from laying hens in Belgium to antibiotics and disinfectants and integron prevalence. Avian Dis. 2014, 58, 271–278. [Google Scholar] [CrossRef]
  31. Maertens, H.; De Reu, K.; Meyer, E.; Van Coillie, E.; Dewulf, J. Limited association between disinfectant use and either antibiotic or disinfectant susceptibility of Escherichia coli in both poultry and pig husbandry. BMC Vet. Res. 2019, 15, 310. [Google Scholar] [CrossRef]
  32. Puangseree, J.; Jeamsripong, S.; Prathan, R.; Pungpian, C.; Chuanchuen, R. Resistance to widely-used disinfectants and heavy metals and cross resistance to antibiotics in Escherichia coli isolated from pigs, pork and pig carcass. Food Control 2021, 124, 107892. [Google Scholar] [CrossRef]
  33. Neuhaus, S.; Feßler, A.T.; Dieckmann, R.; Thieme, L.; Pletz, M.W.; Schwarz, S.; Al Dahouk, S. Towards a harmonized terminology: A glossary for biocide susceptibility testing. Pathogens 2022, 11, 1455. [Google Scholar] [CrossRef]
  34. Schug, A.R.; Scholtzek, A.D.; Turnidge, J.; Meurer, M.; Schwarz, S.; Feßler, A.T.; the Biocide Susceptibility Study Group. Development of quality control ranges for biocide susceptibility testing. Pathogens 2022, 11, 223. [Google Scholar] [CrossRef]
  35. EUCAST. The European Committee on Antimicrobial Susceptibility Testing. MIC and Zone Diameter Distributions and ECOFFs. 2022. Available online: https://mic.eucast.org/search/?search%5Bmethod%5D=mic&search%5Bantibiotic%5D=-1&search%5Bspecies%5D=261&search%5Bdisk_content%5D=-1&search%5Blimit%5D=50 (accessed on 29 November 2022).
  36. Sjölund, M.; Bengtsson, S.; Bonnedahl, J.; Hernandez, J.; Olsen, B.; Kahlmeter, G. Antimicrobial susceptibility in Escherichia coli of human and avian origin—A comparison of wild-type distributions. Clin. Microbiol. Infect. 2009, 15, 461–465. [Google Scholar] [CrossRef]
  37. EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 13.0. 2022. Available online: https://www.eucast.org/clinical_breakpoints/ (accessed on 12 December 2022).
  38. Galler, H.; Luxner, J.; Petternel, C.; Reinthaler, F.F.; Habib, J.; Haas, D.; Kittinger, C.; Pless, P.; Feierl, G.; Zarfel, G. Multiresistant bacteria isolated from intestinal faeces of farm animals in Austria. Antibiotics 2021, 10, 466. [Google Scholar] [CrossRef]
  39. Musa, L.; Proietti, P.C.; Marenzoni, M.L.; Stefanetti, V.; Kika, T.S.; Blasi, F.; Magistrali, C.F.; Toppi, V.; Ranucci, D.; Branciari, R.; et al. Susceptibility of commensal E. coli isolated from conventional, antibiotic-free, and organic meat chickens on farms and at slaughter toward antimicrobials with public health relevance. Antibiotics 2021, 10, 1321. [Google Scholar] [CrossRef]
  40. Costa, M.M.; Cardo, M.; Soares, P.; Cara d’Anjo, M.; Leite, A. Multi-drug and β-lactam resistance in Escherichia coli and food-borne pathogens from animals and food in Portugal, 2014–2019. Antibiotics 2022, 11, 90. [Google Scholar] [CrossRef]
  41. Ayandele, A.; Oladipo, E.; Oyebisi, O.; Kaka, M. Prevalence of multi-antibiotic resistant Escherichia coli and Klebsiella species obtained from a tertiary medical institution in Oyo State, Nigeria. Qatar Med. J. 2020, 2020, 9. [Google Scholar] [CrossRef]
  42. El Mekes, A.; Zahlane, K.; Ait Said, L.; Tadlaoui Ouafi, A.; Barakate, M. The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco. J. Infect. Public Health 2020, 13, 637–643. [Google Scholar] [CrossRef]
  43. Benaissa, E.; Elmrimar, N.; Belouad, E.; Mechal, Y.; Ghazouani, M.; Bsaibiss, F.; Benlahlou, Y.; Chadli, M.; Touil, N.; Lemnaouer, A.; et al. Update on the resistance of Escherichia coli isolated from urine specimens in a Moroccan hospital: A review of a 7-year period. Germs 2021, 11, 189–198. [Google Scholar] [CrossRef]
  44. Di Carlo, P.; Serra, N.; Lo Sauro, S.; Carelli, V.M.; Giarratana, M.; Signorello, J.C.; Lucchesi, A.; Manta, G.; Napolitano, M.S.; Rea, T.; et al. Epidemiology and pattern of resistance of gram-negative bacteria isolated from blood samples in hospitalized patients: A single center retrospective analysis from southern Italy. Antibiotics 2021, 10, 1402. [Google Scholar] [CrossRef]
  45. Piazza, A.; Principe, L.; Comandatore, F.; Perini, M.; Meroni, E.; Mattioni Marchetti, V.; Migliavacca, R.; Luzzaro, F. Whole-genome sequencing investigation of a large nosocomial outbreak caused by ST131 H30Rx KPC-producing Escherichia coli in Italy. Antibiotics 2021, 10, 718. [Google Scholar] [CrossRef] [PubMed]
  46. RKI. Robert Koch Institute. Antibiotika-Resistenz-Surveillance. 2021. Available online: https://ars.rki.de/Content/Database/ResistanceOverview.aspx (accessed on 17 January 2023).
  47. Rhomberg, P.R.; Jones, R.N. Summary trends for the meropenem yearly susceptibility test information collection program: A 10-year experience in the United States (1999–2008). Diagn. Microbiol. Infect. Dis. 2009, 65, 414–426. [Google Scholar] [CrossRef] [PubMed]
  48. WHO. World Health Organization, Electronic Essential Medicines List (eEML). Available online: https://list.essentialmeds.org/ (accessed on 6 December 2022).
  49. Kelesidis, T.; Karageorgopoulos, D.E.; Kelesidis, I.; Falagas, M.E. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: A systematic review of the evidence from microbiological and clinical studies. J. Antimicrob. Chemother. 2008, 62, 895–904. [Google Scholar] [CrossRef] [PubMed]
  50. Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL). BVL-Report 15.2 Berichte zur Lebensmittelsicherheit Zoonosen-Monitoring 2019. 2020. Available online: https://www.bvl.bund.de/SharedDocs/Downloads/01_Lebensmittel/04_Zoonosen_Monitoring/Zoonosen_Monitoring_Bericht_2019.pdf?__blob=publicationFile&v=5 (accessed on 15 December 2022).
  51. Guenther, S.; Falgenhauer, L.; Semmler, T.; Imirzalioglu, C.; Chakraborty, T.; Roesler, U.; Roschanski, N. Environmental emission of multiresistant Escherichia coli carrying the colistin resistance gene mcr-1 from German swine farms. J. Antimicrob. Chemother. 2017, 72, 1289–1292. [Google Scholar] [CrossRef]
  52. Abdalla, S.E.; Abia, A.L.K.; Amoako, D.G.; Perrett, K.; Bester, L.A.; Essack, S.Y. From farm-to-fork: E. coli from an intensive pig production system in South Africa shows high resistance to critically important antibiotics for human and animal use. Antibiotics 2021, 10, 178. [Google Scholar] [CrossRef]
  53. Ketkhao, P.; Thongratsakul, S.; Poolperm, P.; Poolkhet, C.; Amavisit, P. Antimicrobial resistance profiles of Escherichia coli from swine farms using different antimicrobials and management systems. Vet. World 2021, 14, 689–695. [Google Scholar] [CrossRef]
  54. Martelli, F.; AbuOun, M.; Cawthraw, S.; Storey, N.; Turner, O.; Ellington, M.; Nair, S.; Painset, A.; Teale, C.; Anjum, M.F. Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom. J. Antimicrob. Chemother. 2021, 77, 846–848. [Google Scholar] [CrossRef]
  55. SCENIHR. Scientific Committee on Emerging and Newly Identified Health Risks. Assessment of the Antibiotic Resistance Effects of Biocides. 2009. Available online: https://health.ec.europa.eu/scientific-committees/former-scientific-committees/scientific-committee-emerging-and-newly-identified-health-risks-scenihr_en (accessed on 15 December 2022).
  56. Rezasoltani, S.; Yadegar, A.; Hatami, B.; Asadzadeh Aghdaei, H.; Zali, M.R. Antimicrobial resistance as a hidden menace lurking behind the COVID-19 outbreak: The global impacts of too much hygiene on AMR. Front. Microbiol. 2020, 11, 590683. [Google Scholar] [CrossRef]
  57. Ansari, S.; Hays, J.P.; Kemp, A.; Okechukwu, R.; Murugaiyan, J.; Ekwanzala, M.D.; Ruiz Alvarez, M.J.; Paul-Satyaseela, M.; Iwu, C.D.; Balleste-Delpierre, C.; et al. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: An AMR Insights global perspective. JAC Antimicrob. Resist. 2021, 3, dlab038. [Google Scholar] [CrossRef]
  58. Rizvi, S.G.; Ahammad, S.Z. COVID-19 and antimicrobial resistance: A cross-study. Sci. Total Environ. 2022, 807, 150873. [Google Scholar] [CrossRef]
  59. Wand, M.E.; Bock, L.J.; Bonney, L.C.; Sutton, J.M. Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob. Agents Chemother. 2017, 61, e01162-16. [Google Scholar] [CrossRef]
  60. Fernando, D.M.; Xu, W.; Loewen, P.C.; Zhanel, G.G.; Kumar, A. Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics. Antimicrob. Agents Chemother. 2014, 58, 6424–6431. [Google Scholar] [CrossRef]
  61. Partridge, S.R.; Kwong, S.M.; Firth, N.; Jensen, S.O. Mobile genetic elements associated with antimicrobial resistance. Clin. Microbiol. Rev. 2018, 31, e00088-17. [Google Scholar] [CrossRef]
  62. Lavilla Lerma, L.; Benomar, N.; Casado Muñoz, M.d.C.; Gálvez, A.; Abriouel, H. Correlation between antibiotic and biocide resistance in mesophilic and psychrotrophic Pseudomonas spp. isolated from slaughterhouse surfaces throughout meat chain production. Food Microbiol. 2015, 51, 33–44. [Google Scholar] [CrossRef]
  63. Oggioni, M.R.; Coelho, J.R.; Furi, L.; Knight, D.R.; Viti, C.; Orefici, G.; Martinez, J.L.; Freitas, A.T.; Coque, T.M.; Morrissey, I. Significant differences characterise the correlation coefficients between biocide and antibiotic susceptibility profiles in Staphylococcus aureus. Curr. Pharm. Des. 2015, 21, 2054–2057. [Google Scholar] [CrossRef]
  64. Adkin, P.; Hitchcock, A.; Smith, L.J.; Walsh, S.E. Priming with biocides: A pathway to antibiotic resistance? J. Appl. Microbiol. 2022, 133, 830–841. [Google Scholar] [CrossRef]
  65. Christensen, E.G.; Gram, L.; Kastbjerg, V.G. Sublethal Triclosan Exposure Decreases Susceptibility to Gentamicin and Other Aminoglycosides in Listeria monocytogenes. Antimicrob. Agents Chemother. 2011, 55, 4064–4071. [Google Scholar] [CrossRef]
  66. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 10th ed.; CLSI Document Ms07-A10; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2015. [Google Scholar]
Antibiotics 12 00823 g001 550
Figure 1. Proportion of antimicrobial-resistant isolates from swine feces (orange), pork meat (red), voluntary donors (light blue) and inpatients (dark blue).
Figure 1. Proportion of antimicrobial-resistant isolates from swine feces (orange), pork meat (red), voluntary donors (light blue) and inpatients (dark blue).
Antibiotics 12 00823 g001
Table
Table 1. Minimum inhibitory concentrations of biocides in E. coli of human and porcine origin.
Table 1. Minimum inhibitory concentrations of biocides in E. coli of human and porcine origin.
BiocideOrigin of IsolatesNumber of Isolates with MIC Values (mg/L) ofMIC95p-Value
0.250.51248163264128256512102420484096819216,38432,76865,536131,072262,144
GDASwine feces --18811--- 5120.002
Pork meat --15822--- 512
Voluntary donors --166713--- 1024
Inpatients --38861-- 1024
CHGSwine feces -12799---- 4<0.0001
Pork meat 7503921--- 2
Voluntary donors -777912-- 4
Inpatients -118133--- 4
BACSwine feces ---30673-- 320.239
Pork meat ---1881--- 32
Voluntary donors --328623-- 32
Inpatients --12954131- 64
OCTSwine feces--496---- 20.088
Pork meat--1962--- 2
Voluntary donors--1923--- 2
Inpatients--1943--- 2
IPASwine feces ---454402-65,5360.022
Pork meat ---158355-131,072
Voluntary donors ---551391-65,536
Inpatients ---138581-65,536
NaOClSwine feces --15796-- 10240.016
Pork meat --22761-- 512
Voluntary donors --2666-- 1024
Inpatients --593--- 512
PCMCSwine feces --57421--- 5120.001
Pork meat --8118---- 512
Voluntary donors -16827---- 512
Inpatients -27323---- 512
GDA = glutaraldehyde; CHG = chlorhexidine digluconate; BAC = benzalkonium chloride; OCT = octenidine dihydrochloride; IPA = isopropanol; NaOCl = sodium hypochlorite; PCMC = chlorocresol. MIC = minimum inhibitory concentration. MIC95 = lowest concentration inhibiting growth of 95% of the bacterial population. Kruskal–Wallis test was applied to identify differences between the MIC distributions of subgroups. Differences were considered significant at p < 0.05. The grey areas are the test ranges not included in the test panels for the respective substance.
Table
Table 2. Minimum bactericidal concentrations of biocides in E. coli of human and porcine origin.
Table 2. Minimum bactericidal concentrations of biocides in E. coli of human and porcine origin.
BiocideOrigin of IsolatesNumber of Isolates with MBC Values (mg/L) ofMBC95p-Value
0.250.51248163264128256512102420484096819216,38432,76865,536131,072262,144
GDASwine feces --9874--- 5120.004
Pork meat --6903--- 512
Voluntary donors --1168161-- 1024
Inpatients --378161-- 1024
CHGSwine feces -10731421-- 4<0.0001
Pork meat 6493761--- 4
Voluntary donors -4751232-- 8
Inpatients -957247-1- 8
BACSwine feces ---137116-- 640.069
Pork meat ---774162- 64
Voluntary donors --1226013-- 64
Inpatients --12352202- 64
OCTSwine feces--382123-- 40.704
Pork meat---83115-- 8
Voluntary donors--18294-- 4
Inpatients---81116-- 8
IPASwine feces ----419733131,0720.009
Pork meat ----4126518262,144
Voluntary donors ---1319685262,144
Inpatients ----518732131,072
NaOClSwine feces ---86131- 10240.178
Pork meat ---918-- 1024
Voluntary donors --572181- 1024
Inpatients ---926-- 1024
PCMCSwine feces --1909--- 10240.022
Pork meat ---99---- 512
Voluntary donors --28410--- 1024
Inpatients -12923--- 512
GDA = glutaraldehyde; CHG = chlorhexidine digluconate; BAC = benzalkonium chloride; OCT = octenidine dihydrochloride; IPA = isopropanol; NaOCl = sodium hypochlorite; PCMC = chlorocresol. MBC = minimum bactericidal concentration. MBC95 = lowest lethal concentration killing 95% of the bacterial population. Kruskal–Wallis test was applied to identify differences between the MBC distributions of subgroups. Differences were considered significant at p < 0.05. The grey areas are the test ranges not included in the test panels for the respective substance.
Table
Table 3. Frequency of antimicrobial resistance in non-ESBL and ESBL E. coli isolates.
Table 3. Frequency of antimicrobial resistance in non-ESBL and ESBL E. coli isolates.
AntimicrobialsSwine Feces, n (%)Pork Meat, n (%)Voluntary Donors, n (%)Inpatients, n (%)Total, n (%)
ESBL
(n = 48)		Non-ESBL
(n = 52)		ESBL
(n = 44)		Non-ESBL
(n = 55)		ESBL
(n = 51)		Non-ESBL
(n = 45)		ESBL
(n = 73)		Non-ESBL (n = 25)E. coli
(n = 393)
Ampicillin48 (100)17 (33)44 (100)17 (31)51 (100)12 (27)73 (100)16 (64)278 (71)
Cefotaxime48 (100)044 (100)051 (100)073 (100)0214 (55)
Ceftazidime48 (100)042 (95)051 (100)072 (99)0211 (54)
Meropenem00001 (2)04 (5)05 (1)
Nalidixic acid11 (23)5 (10)12 (27)3 (5)32 (63)6 (13)60 (82)14 (56)143 (36)
Ciprofloxacin12 (25)7 (13)13 (30)3 (5)33 (65)7 (16)59 (81)14 (56)148 (38)
Gentamicin4 (8)2 (4)6 (14)1 (2)7 (14)3 (7)11 (15)1 (4)35 (9)
Tetracycline30 (63)21 (40)22 (50)20 (36)30 (59)11 (24)41 (56)10 (40)185 (47)
Tigecycline1 (2)00000001 (0.3)
Colistin7 (15)1 (2)01 (2)02 (4)0011 (3)
Sulfamethoxazole31 (65)16 (31)30 (68)18 (33)42 (82)10 (22)53 (73)12 (48)212 (54)
Trimethoprim28 (58)11 (21)26 (59)18 (33)43 (84)9 (20)52 (71)13 (52)200 (51)
Chloramphenicol13 (27)5 (10)5 (11)9 (16)8 (16)3 (7)16 (22)4 (16)63 (16)
Azithromycin10 (21)1 (2)9 (21)016 (31)3 (7)24 (33)5 (20)68 (17)
ESBL = Extended-spectrum β-lactamase-producing E. coli.
Table
Table 4. Significant positive correlation coefficients (rs) between biocides (MIC or MBC) and antimicrobials (MIC) in 393 E. coli isolates.
Table 4. Significant positive correlation coefficients (rs) between biocides (MIC or MBC) and antimicrobials (MIC) in 393 E. coli isolates.
AntimicrobialsBiocides
GlutaraldehydeChlorhexidine DigluconateBenzalkonium Chloride
MICMBCMICMBCMICMBC
Ampicillin----0.119 **0.121 *
Cefotaxime-0.100 *-0.117 *--
Ceftazidime----0.111 *-
Meropenem0.127 *0.110 *----
Nalidixic acid0.113 *-0.198 **0.280 **0.136 **-
Ciprofloxacin0.109 *-0.208 **0.276 **0.144 **-
Gentamicin0.164 **-0.228 **0.195 ** -
Tetracycline--0.229 **0.246 **0.100 *-
Tigecycline-----0.121 *
Sulfamethoxazole----0.155 **0.128 *
Trimethoprim----0.144 **0.155 **
Chloramphenicol--0.109 *0.103 *-0.099 *
Azithromycin--0.152 **0.138 **0.173 **0.152**
MIC = minimum inhibitory concentration; MBC = minimum bactericidal concentration; * correlation is significant at the 0.05 level; ** correlation is significant at the 0.01 level.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

da Silva, D.A.V.; Dieckmann, R.; Makarewicz, O.; Hartung, A.; Bethe, A.; Grobbel, M.; Belik, V.; Pletz, M.W.; Al Dahouk, S.; Neuhaus, S. Biocide Susceptibility and Antimicrobial Resistance of Escherichia coli Isolated from Swine Feces, Pork Meat and Humans in Germany. Antibiotics 2023, 12, 823. https://doi.org/10.3390/antibiotics12050823

AMA Style

da Silva DAV, Dieckmann R, Makarewicz O, Hartung A, Bethe A, Grobbel M, Belik V, Pletz MW, Al Dahouk S, Neuhaus S. Biocide Susceptibility and Antimicrobial Resistance of Escherichia coli Isolated from Swine Feces, Pork Meat and Humans in Germany. Antibiotics. 2023; 12(5):823. https://doi.org/10.3390/antibiotics12050823

Chicago/Turabian Style

da Silva, David Attuy Vey, Ralf Dieckmann, Oliwia Makarewicz, Anita Hartung, Astrid Bethe, Mirjam Grobbel, Vitaly Belik, Mathias W. Pletz, Sascha Al Dahouk, and Szilvia Neuhaus. 2023. "Biocide Susceptibility and Antimicrobial Resistance of Escherichia coli Isolated from Swine Feces, Pork Meat and Humans in Germany" Antibiotics 12, no. 5: 823. https://doi.org/10.3390/antibiotics12050823

APA Style

da Silva, D. A. V., Dieckmann, R., Makarewicz, O., Hartung, A., Bethe, A., Grobbel, M., Belik, V., Pletz, M. W., Al Dahouk, S., & Neuhaus, S. (2023). Biocide Susceptibility and Antimicrobial Resistance of Escherichia coli Isolated from Swine Feces, Pork Meat and Humans in Germany. Antibiotics, 12(5), 823. https://doi.org/10.3390/antibiotics12050823

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop